Jonathan Freeman

Dr. Jonathan E.
Freeman is a Chief Executive Officer at Artbio, Inc. and an Independent Director at Phio Pharmaceuticals Corp.
He is on the Board of Directors at Phio Pharmaceuticals Corp.
Dr. Freeman was previously employed as a Chief Operating Officer by Anthos Therapeutics, Inc., a Senior Advisor by Blackstone Life Sciences Advisors LLC, a Chief Business Officer by Vedanta Biosciences, Inc., a Senior Vice President & Head-Strategy Development by Merck KGaA, a Director-Mergers & Acquisitions by Baxter Healthcare Corp., a Head-Licensing by Serono, Inc., and a Director & Vice President by Swiss-PLG.
He received his undergraduate degree from the University of Cambridge, a graduate degree from the University of Cambridge and an MBA from Webster University.